For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
- XELODA labeling, 3/19/2015
- XELODA Safety and Utilization Review
- Presentation: Xeloda (capecitabine)
- XELODA Clinical Review
- XELODA Clinical Pharmacology Review
- XELODA Statistical Review